Onset : Effects may vary
Submit the PA to the plan
Semaglutide (Wegovy, Ozempic, and Rybelsus) Semaglutide is in a category of prescription drugs called glucagon-like peptide-1 agonists, or GLP-1s, and they have upended the way obesity is treated
P-glycoprotein: data reporting interactions not available
67, 76 The role of the proliferative effect on PSCs of liraglutide and the other GPCRs in AP or CP at present is unknown, as is the possibility that prolonged treatment with GLP-1R agonists for diabetes or other diseases, may lead to increased fibrosis due to enhanced PSC growth and activation
Because these medications work in part by slowing how quickly food leaves the stomach, the most frequent GLP-1 side effects are gastrointestinal symptoms, such as: Nausea Vomiting Diarrhea Constipation Upset stomach or heartburn These symptoms are usually most pronounced during the first few weeks of treatment or after a dose increase